We generate global-proteomic and phospho-proteomic data for a panel of 50 glioma tissues (39 IDH wild-type GBMs) with previously annotated genomic, transcriptomic, and clinical information as well as the responses of matched neurosphere-like patient-derived cells (PDCs) to targeted therapies. Here, IDH1 is linked to central nervous system cancer.